发明名称 METHOD FOR TREATING NON-SMALL CELL LUNG CANCER
摘要 <p>The present invention provides methods for treating a human patient afflicted with unresectable, advanced or metastatic non-small cell lung cancer comprising periodically administering to the human patient chemotherapy comprising an amount of docetaxel; and 640mg of an anti-clusterin oligonucleotide having the sequence CAGCAGCAGAGTCTTCATCAT (SEQ ID NO: 1 ), wherein the anti-clusterin oligonucleotide has a phosphorothioate backbone throughout, has sugar moieties of nucleotides 1-4 and 18-21 bearing 2'-0-methoxyethyl modifications, has nucleotides 5-17 which are 2'deoxynucleotides, and has 5-methylcytosines at nucleotides 1, 4, and 19, thereby treating the human patient afflicted with unresectable, advanced or metastatic non-small cell lung cancer. The present invention also provides compositions and combinations, packages, and uses thereof for treating a human patient afflicted with unresectable, advanced or metastatic non-small cell lung cancer.</p>
申请公布号 WO2013173757(A8) 申请公布日期 2015.04.30
申请号 WO2013US41652 申请日期 2013.05.17
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;DUKSIN, CHEN;TESSLER, SHOSHI 发明人 DUKSIN, CHEN;TESSLER, SHOSHI
分类号 A61K31/7105 主分类号 A61K31/7105
代理机构 代理人
主权项
地址